Prevention of neonatal ophthalmia

Prevention of neonatal ophthalmia refers to prophylactic measures administered to newborns within the first month of life to inhibit the development of ophthalmia neonatorum, an acute conjunctival infection most commonly transmitted vertically during passage through an infected birth canal The target population consists of neonates at risk of ocular colonization by maternal genital pathogens, most critically *Neisseria gonorrhoeae* and *Chlamydia trachomatis* Prophylaxis is primarily intended to...

Prevention of neonatal ophthalmia refers to prophylactic measures administered to newborns within the first month of life to inhibit the development of ophthalmia neonatorum, an acute conjunctival infection most commonly transmitted vertically during passage through an infected birth canal The target population consists of neonates at risk of ocular colonization by maternal genital pathogens, most critically *Neisseria gonorrhoeae* and *Chlamydia trachomatis*

Prevention of neonatal ophthalmia refers to prophylactic measures administered to newborns within the first month of life to inhibit the development of ophthalmia neonatorum, an acute conjunctival infection most commonly transmitted vertically during passage through an infected birth canal

Clinically and pathophysiologically, unrestrained microbial invasion of the conjunctiva triggers hyperacute ocular inflammation characterized by marked eyelid edema, chemosis, and copious purulent discharge Prophylaxis is primarily intended to avert the rapid progression of untreated gonococcal infection, which can penetrate intact corneal epithelium and lead to corneal ulceration, globe perforation, and permanent blindness

Prophylaxis is primarily intended to avert the rapid progression of untreated gonococcal infection, which can penetrate intact corneal epithelium and lead to corneal ulceration, globe perforation, and permanent blindness